<DOC>
	<DOCNO>NCT01329705</DOCNO>
	<brief_summary>The purpose study examine effectiveness onabotulinum toxin A ( BTX ) injection ( tone management ) dynamic splint ( contracture reduction ) improve gait pattern patient spastic hypertnoia due stroke traumatic brain injury resultant excessive plantarflexion .</brief_summary>
	<brief_title>Dynamic Splinting Plantarflexion Spastic Hemiplegia</brief_title>
	<detailed_description />
	<mesh_term>Muscle Spasticity</mesh_term>
	<mesh_term>Hemiplegia</mesh_term>
	<criteria>Patients enrol male female , least 18 year age , diagnose spastic hemiplegia excessive plantarflexion , include follow : 1 . Diagnosis stroke traumatic brain injury 6 month prior enrollment study 2 . Reduced AROM PROM ankle dorsiflexion 3 . Ability ambulate safely 20 foot without anklefoot orthosis ( AFO ) 4 . Inability ambulate initial heelcontact 5 . No prior BTX treatment within 6 month 6 . R1 10° great ( use Tardeiu method assessment ) 7 . Mean Ashworth Scale Test ≥3 plantarflexors 1 . Bell 's Palsy 2 . Viral Encephalitis 3 . Muscular Dystrophy 4 . Multiple Sclerosis 5 . Prior heelcord lengthen tendontransfer procedure foot/ankle 6 . Subjects fixed contracture ankle 7 . Female subject pregnant ( positive urine pregnancy test ) , infant breastfeeding , childbearing potential practice reliable method birth control 8 . Bleeding disorder 9 . Diagnosis disease may interfere neuromuscular function ( ie . Myasthenia Gravis , LambertEaton Myasthenic Syndrome , amyotrophic lateral sclerosis ) 10 . Subjects currently use aminoglycoside antibiotic , curarelike agent , agent may interfere neuromuscular function 11 . Subjects profound weakness atrophy muscle target area injection 12 . Active systemic infection infection injection site 13 . Allergy sensitivity botulinum toxin A</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>August 2013</verification_date>
</DOC>